SCHEMBL2348660

SCHEMBL2348660

CN1CCC(CCNc2cccc(S(=O)(=O)n3ccc4cc(F)ccc43)c2)CC1

nearest known ligand 0.50

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 16/20 0.50
CYP3A4 P08684 1/20 0.44
FGFR4 P22455 1/20 0.41
EPHX2 P34913 1/20 0.41
PPARG P37231 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2348423 0.91 HTR6 (0.51) HTR6CYP3A4FGFR4
SCHEMBL2268963 0.85 HTR6 (0.54) HTR6CYP3A4FGFR4
Hydrochloric Acid SCHEMBL2269614 0.85 HTR6 (0.53) HTR6CYP3A4FGFR4
SCHEMBL2364813 0.84 HTR6 (0.48) HTR6CYP3A4
SCHEMBL2270927 0.79 HTR6 (0.52) HTR6CYP3A4
SCHEMBL2355547 0.79 HTR6 (0.56) HTR6CYP3A4FGFR4PPARG
SCHEMBL2275339 0.78 HTR6 (0.48) HTR6EPHX2PPARG
SCHEMBL4762974 0.78 VCP (0.41) HTR6
SCHEMBL1971519 0.78 HTR6 (0.55) HTR6CYP3A4
SCHEMBL1356234 0.75 HTR6 (0.76) HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US claimed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US claimed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP claimed
US-7998981-B2 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES LIMITED (IN) 2011-08-16 US disclosed
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands SUVEN LIFE SCIENCES, LTD. (IN) 2010-07-01 US disclosed
EP-1919896-B1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LTD (IN) 2009-12-23 EP disclosed
EP-1919896-A1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. Suven Life Sciences Limited (IN) 2008-05-14 EP disclosed
WO-2007020652-A1 AMINOARYL SULPHONAMIDE DERIVATIVES AS FUNCTIONAL 5-HT6 LIGANDS. SUVEN LIFE SCIENCES LIMITED (IN) 2007-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168168-A1 Aminoaryl sulphonamide derivatives as functional 5-HT6 ligands HTR6, HTR5A, HTR3B HTR6 1/4885CYP3A4 478/4885FGFR4 1857/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.